Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ULTRAVIST (PHARMACY BULK)

IOPROMIDE

Standard Dose
62.3%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ULTRAVIST (PHARMACY BULK) is listed in Drugs@FDA under application 021425 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IOPROMIDE Form and strength INJECTABLE;INJECTION - 62.3% Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2023-06-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ULTRAVIST (PHARMACY BULK) is listed in Drugs@FDA under application 021425 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IOPROMIDE Form and strength INJECTABLE;INJECTION - 62.3% Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2023-06-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.